As always I prefer to get my information from the company through ASX announcements rather than media reports as it is easy for anyone to say they were 'misquoted' in a media article ?
The article also states "The Victor Chang Cardiac Research Institute will spearhead the Australian end of a larger trial of the MSC treatment, which has shown outstanding results in a small sample of patients in New York" .... that would indicate IMO that we are part of the 300 patient trial ?
Again I will wait to see what MSB announces to be sure if this is the case or if this is a new trial in Australia for COVID-19 patients with heart problems ? SI has said that Melbourne and Sydney would feature in an Australian trial so we will know for sure the 'set up' of this once the company announces it, which could be today or later once this trial begins ?
GLTAH
Mesoblast(?) Australian Covid-19 Trial Victor Chang Cardiac Research Institute, page-66
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |